TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7779317

Group type: EXPERIMENTAL
Intervention: Self-help video for insomniacs
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Therapist guidance supplementing self-help video for insomniacs
Number of subjects: 100

Group type: COMPARATOR
Intervention: Waiting-list control group of senior insomniacs
Number of subjects: 100
Study: 2276653

Group type: EXPERIMENTAL
Intervention: Cervical dilatation (Group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No cervical dilatation (Group B)
Number of subjects: 60
Study: 7440694

Group type: EXPERIMENTAL
Intervention: Metoclopramide (10 mg, iv) at 2300 h
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Metoclopramide (10 mg, iv) at 1100 h
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 31384636

Group type: EXPERIMENTAL
Intervention: Ropinirole hydrochloride extended-release tablet (Requip CR) at 2- to 16-mg doses
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ropinirole hydrochloride extended-release tablet (Requip CR)
Number of subjects: 20
Study: 28169881

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 14684

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14684
Study: 25904442

Group type: EXPERIMENTAL
Intervention: Peg Intron (PEG‐IFNα‐2b)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pegasys (PEG‐IFNα‐2a)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Reiveron Retard (PEG‐IFNα‐2a)
Number of subjects: 60
Study: 22726906

Group type: EXPERIMENTAL
Intervention: Adaptable automation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Static automation (low, medium, high)
Number of subjects: 40
Study: 21966817

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (20 mg, vaginally every 6 hours, maximum 3 times)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Dinoprostone (0.5 mcg, vaginally every 6 hours, maximum 3 times)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Dinoprostone (0.5 mcg)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (20 mg)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 66
Study: 19375870

Group type: EXPERIMENTAL
Intervention: Comprehensive, behaviorally‐based family intervention for dual disorders program (FIDD)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Shorter‐term family psychoeducational program (FPE)
Number of subjects: 2
Study: 17352450

Group type: EXPERIMENTAL
Intervention: Various therapeutic agents used in the management of Polycythaemia Vera
Number of subjects: 0
Study: 15627052

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 0
Study: 11181659

Group type: EXPERIMENTAL
Intervention: Adjuvant systemic therapy
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Computer algorithm for calculating 10-year absolute outcome data
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Comparison with previously described actuarial algorithm
Number of subjects: 11
Study: 9240689

Group type: EXPERIMENTAL
Intervention: MDCK-derived vaccine
Number of subjects: 114

Group type: COMPARATOR
Intervention: Egg-derived vaccine
Number of subjects: 114
Study: 7962681

Group type: EXPERIMENTAL
Intervention: Sustained-release adinazolam
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206
Study: 3296606

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine with 8% glucose
Number of subjects: 41

Group type: COMPARATOR
Intervention: 0.5% bupivacaine without glucose
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine with and without glucose
Number of subjects: 41
Study: 29334675

Group type: EXPERIMENTAL
Intervention: Pose running retraining (three 2-h sessions)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study: 26404701

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural intervention for depression
Number of subjects: 20

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 20
Study: 25395284

Group type: EXPERIMENTAL
Intervention: Moderate intensity inspiratory muscle training
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham protocol (Control Group)
Number of subjects: 22
Study: 21465325

Group type: EXPERIMENTAL
Intervention: Gabapentin 300 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 20489040

Group type: EXPERIMENTAL
Intervention: Limb muscle fatigue induced by sustained contractions at > or = 80% of maximal voluntary contraction
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham protocol (no muscle fatigue)
Number of subjects: 12
Study: 18537503

Group type: EXPERIMENTAL
Intervention: Virtual reality-based cognitive assessment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified intervention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stroke group
Number of subjects: 0
Study: 14960504

Group type: EXPERIMENTAL
Intervention: Ramipril (1.25 mg/day)
Number of subjects: 4912

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4912
Study: 11772833

Group type: EXPERIMENTAL
Intervention: Head-Down Tilt
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Leg-Up
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Combination of Leg-Up and Head-Down Tilt
Number of subjects: 32

Group type: COMPARATOR
Intervention: Supine
Number of subjects: 32
Study: 9620902

Group type: EXPERIMENTAL
Intervention: Resistive load of 3 cm H2O/L/s
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Resistive load of 6 cm H2O/L/s
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Resistive loads of 3 and 6 cm H2O/L/s
Number of subjects: 18
Study: 7866912

Group type: EXPERIMENTAL
Intervention: Tricalcium phosphate (TP)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Calcium carbonate (CC)
Number of subjects: 24
Study: 2523099

Group type: EXPERIMENTAL
Intervention: OKT3
Number of subjects: 51

Group type: COMPARATOR
Intervention: ATG
Number of subjects: 51
Study: 28939

Group type: EXPERIMENTAL
Intervention: Sultopride
Number of subjects: 50

Group type: COMPARATOR
Intervention: Fluanisone
Number of subjects: 50
Study: 31858116

Group type: EXPERIMENTAL
Intervention: JENVAC
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: JENVAC/JENVAC
Number of subjects: 360

Group type: COMPARATOR
Intervention: SA 14-14-2
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 360
Study: 31600006

Group type: EXPERIMENTAL
Intervention: High-power (HP) radiofrequency application at 50W anterior, 40W posterior, and 30W on the esophagus
Number of subjects: 60

Group type: COMPARATOR
Intervention: Medium-power (MP) radiofrequency application at 40W anterior and 30W posterior
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low-power (LP) radiofrequency application at 30W anterior and 20W posterior
Number of subjects: 60
Study: 29246257

Group type: EXPERIMENTAL
Intervention: Brief intervention plus multidisciplinary intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Brief intervention
Number of subjects: 0
Study: 26667662

Group type: EXPERIMENTAL
Intervention: hFSH stimulation
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: rFSH stimulation
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: hFSH and rFSH
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: AMH and FSH levels
Number of subjects: 221
Study: 23761206

Group type: EXPERIMENTAL
Intervention: e‐Training (internet‐based)
Number of subjects: 599

Group type: COMPARATOR
Intervention: Group fitness ('Face‐to‐Face')
Number of subjects: 599

Group type: COMPARATOR
Intervention: Individually supervised training ('Face‐to‐Face')
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Combined program (Face‐to‐Face and e‐Training)
Number of subjects: 599

Group type: COMPARATOR
Intervention: Group fitness intervention (Study 1)
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: e‐Training (Study 2)
Number of subjects: 599
Study: 21792072

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) training
Number of subjects: 9

Group type: COMPARATOR
Intervention: Conventional strength training (CST)
Number of subjects: 9
Study: 19098860

Group type: EXPERIMENTAL
Intervention: linaclotide 100 microg/day
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: linaclotide 1,000 microg/day
Number of subjects: 42

Group type: COMPARATOR
Intervention: linaclotide (100, 300, or 1,000 microg)
Number of subjects: 42

Group type: COMPARATOR
Intervention: linaclotide
Number of subjects: 42
Study: 16808989

Group type: EXPERIMENTAL
Intervention: Carnitine supplementation (20mg/kg/day)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 15298560

Group type: EXPERIMENTAL
Intervention: Standardized house dust mite immunotherapy (SIT)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Standard pharmacotherapy
Number of subjects: 12
Study: 11358645

Group type: EXPERIMENTAL
Intervention: HRT+simvastatin (10 mg/day)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: HRT+bezafibrate (400 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: HRT only (control group)
Number of subjects: 30
Study: 10225747

Group type: EXPERIMENTAL
Intervention: Low-density lipoprotein (LDL) apheresis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LDL apheresis
Number of subjects: 0
Study: 11548225

Group type: EXPERIMENTAL
Intervention: Glucosamine sulfate 500 mg t.i.d.
Number of subjects: 200

Group type: COMPARATOR
Intervention: Ibuprofen 400 mg t.i.d.
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 200
Study: 3324330

Group type: EXPERIMENTAL
Intervention: Transparent polyurethane dressings
Number of subjects: 41

Group type: COMPARATOR
Intervention: Dry gauze dressings
Number of subjects: 41
Study: 30192326

Group type: EXPERIMENTAL
Intervention: Early catheter removal with prazosin 1 mg oral 6 hours before removal
Number of subjects: 142

Group type: COMPARATOR
Intervention: Standard catheter removal
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Early catheter removal
Number of subjects: 142
Study: 27888990

Group type: EXPERIMENTAL
Intervention: Nebulized budesonide (2 mg 3 times/day)
Number of subjects: 410

Group type: COMPARATOR
Intervention: Intravenous methylprednisolone (40 mg/day)
Number of subjects: 410
Study: 24948549

Group type: EXPERIMENTAL
Intervention: Cappella Sideguard (CS) sidebranch stent
Number of subjects: 52

Group type: COMPARATOR
Intervention: Balloon-expandable drug-eluting stents (DES)
Number of subjects: 52
Study: 23910429

Group type: EXPERIMENTAL
Intervention: Intensive target-based medical treatment for cardiac risk factors
Number of subjects: 1750

Group type: EXPERIMENTAL
Intervention: Better risk factor control during the trial
Number of subjects: 1750
Study: 21092089

Group type: EXPERIMENTAL
Intervention: Caffeine (300 mg)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 18208607

Group type: EXPERIMENTAL
Intervention: Structured family meetings (4 sessions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 16340193

Group type: EXPERIMENTAL
Intervention: Mayo Clinic Regimen (MCR) + LV5FU2 (group A)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: MCR + irinotecan (350 mg/m(2)) (group B)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: MCR + FOLFIRI (group C)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: MCR + FOLFOX4 (group D)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: FOLFIRI + FOLFOX4 (group E)
Number of subjects: 193
Study: 14639777

Group type: EXPERIMENTAL
Intervention: AMMA treatments
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 24
Study: 11128883

Group type: EXPERIMENTAL
Intervention: Filler task
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Warm month
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Tuesday
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Credit day
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Time period (1992-1996)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Task type
Number of subjects: 258

Group type: COMPARATOR
Intervention: Timing factors
Number of subjects: 258
Study: 8945029

Group type: EXPERIMENTAL
Intervention: DDDR with SMARTracking (DDDRSM)
Number of subjects: 7

Group type: COMPARATOR
Intervention: DDDR with Conditional Ventricular Tracking Limit (DDDRC)
Number of subjects: 7

Group type: COMPARATOR
Intervention: DDDR with standard upper rate behavior
Number of subjects: 7

Group type: COMPARATOR
Intervention: VVIR
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: DDDRSM
Number of subjects: 7

Group type: COMPARATOR
Intervention: DDDRC
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: DDDRSM and DDDRC
Number of subjects: 7
Study: 1615136

Group type: EXPERIMENTAL
Intervention: 150 mg sodium pentobarbital (SIN)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 180 mg sodium pentobarbital in divided doses (DIV)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 3519416

Group type: EXPERIMENTAL
Intervention: Muzolimine (30 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Furosemide (40 mg)
Number of subjects: 10
Study: 29652768

Group type: EXPERIMENTAL
Intervention: One-stage palatoplasty (Group A)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Two-stage palatoplasty (Group B)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 100
Study: 27716165

Group type: EXPERIMENTAL
Intervention: Laryngeal Tube Suction Disposable (LTS‐D)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Supreme Laryngeal Mask Airway (SLMA)
Number of subjects: 80
Study: 24229434

Group type: EXPERIMENTAL
Intervention: Laparoscopic simple prostatectomy (LSP)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Bipolar transurethral resection of the prostate (B‐TURP)
Number of subjects: 90
Study: 22210087

Group type: EXPERIMENTAL
Intervention: Nonpersistent patients aged <65 years
Number of subjects: 3142

Group type: EXPERIMENTAL
Intervention: Persistent patients aged 65-74 years
Number of subjects: 3142

Group type: EXPERIMENTAL
Intervention: Persistent patients aged ≥75 years
Number of subjects: 3142

Group type: COMPARATOR
Intervention: Nonpersistent patients aged 65-74 years
Number of subjects: 3142

Group type: COMPARATOR
Intervention: Nonpersistent patients aged ≥75 years
Number of subjects: 3142
Study: 20155842

Group type: EXPERIMENTAL
Intervention: VSL#3
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 18716168

Group type: EXPERIMENTAL
Intervention: Flavanol-rich dark chocolate (FRDC) at 100 g/d for 15 days
Number of subjects: 19
Study: 18435368

Group type: EXPERIMENTAL
Intervention: CONSORT Statement adherence
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 15507173

Group type: EXPERIMENTAL
Intervention: Internal mammary sentinel node biopsy
Number of subjects: 707

Group type: COMPARATOR
Intervention: Standard axillary treatment
Number of subjects: 707
Study: 11402408

Group type: EXPERIMENTAL
Intervention: 1-hour drain clamping
Number of subjects: 44

Group type: COMPARATOR
Intervention: 24-hour drain clamping
Number of subjects: 44
Study: 9003262

Group type: EXPERIMENTAL
Intervention: Tracheobronchial cytology in patients with inhalation injury
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control patients (no inhalation injury)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tracheobronchial cytology
Number of subjects: 40
Study: 8236193

Group type: EXPERIMENTAL
Intervention: tranexamic acid
Number of subjects: 44

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 44
Study: 3122528

Group type: EXPERIMENTAL
Intervention: Bulk laxatives containing stimulant type laxative
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Magnesium hydroxide
Number of subjects: 59
Study: 30947293

Group type: EXPERIMENTAL
Intervention: HIV negative women
Number of subjects: 1151

Group type: COMPARATOR
Intervention: HIV-1 infected women
Number of subjects: 1151

Group type: COMPARATOR
Intervention: Newly diagnosed HIV-1 infected women
Number of subjects: 1151

Group type: EXPERIMENTAL
Intervention: Living with friends/in a house-share (among HIV positive women)
Number of subjects: 1151

Group type: EXPERIMENTAL
Intervention: Attending antenatal care (ANC) for the most recent pregnancy (among HIV positive women)
Number of subjects: 1151

Group type: EXPERIMENTAL
Intervention: Living with friends/in a house-share (among HIV negative women)
Number of subjects: 1151
Study: 27038240

Group type: EXPERIMENTAL
Intervention: Redemption Reintegration Services (RRS)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Usual reintegration services
Number of subjects: 115
Study: 24652899

Group type: EXPERIMENTAL
Intervention: REACH II intervention
Number of subjects: 494

Group type: COMPARATOR
Intervention: Education-only intervention
Number of subjects: 494
Study: 23994107

Group type: EXPERIMENTAL
Intervention: Primary debulking surgery (PDS)
Number of subjects: 404

Group type: COMPARATOR
Intervention: Neo-adjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Both treatment arms
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Institutions with good QOL compliance
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Progression free survival
Number of subjects: 404
Study: 21947389

Group type: EXPERIMENTAL
Intervention: JNJ-Q2 (250 mg, twice a day)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Linezolid (600 mg, twice a day)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: JNJ-Q2
Number of subjects: 161

Group type: COMPARATOR
Intervention: Linezolid
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Nausea and vomiting
Number of subjects: 161
Study: 19846653

Group type: EXPERIMENTAL
Intervention: pvl-positive MRSA
Number of subjects: 522

Group type: COMPARATOR
Intervention: pvl-negative MRSA
Number of subjects: 522
Study: 16756534

Group type: EXPERIMENTAL
Intervention: High-energy infant formula (1 kcal mL(‐1)) at full strength from day 1
Number of subjects: 30

Group type: COMPARATOR
Intervention: Diluted high-energy infant formula, graded to full strength over 3 days
Number of subjects: 30
Study: 15361886

Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil (16 mg OD)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg OD)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 11524054

Group type: EXPERIMENTAL
Intervention: Hu23F2G (low-dose 0.3 mg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Hu23F2G (high-dose 1.0 mg/kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Hu23F2G (low-dose and high-dose)
Number of subjects: 60
Study: 9259500

Group type: EXPERIMENTAL
Intervention: Topical Lithium Succinate cream (8% lithium succinate, 0.05% zinc sulphate)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 8518572

Group type: EXPERIMENTAL
Intervention: Nicotine patches
Number of subjects: 600

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 600
Study: 3102711

Group type: EXPERIMENTAL
Intervention: Intravenous gammaglobulin therapy (0.5 g/kg/wk for 1 month in group 1 and during intensive care in group 2)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Intravenous gammaglobulin therapy
Number of subjects: 133

Group type: COMPARATOR
Intervention: Control group (no gammaglobulin therapy)
Number of subjects: 133
Study: 29730330

Group type: EXPERIMENTAL
Intervention: Water-based aerobic training (WA)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Water-based resistance training (WR)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 69
Study: 26962509

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (600 IU/day)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (supplementation free of vitamin D)
Number of subjects: 140
Study: 23532629

Group type: EXPERIMENTAL
Intervention: Epoetin beta (Epo-b) 30000 IU once weekly, increased to 30000 IU twice weekly if Hb increase was <0.5 g/dl after 4 weeks
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Epoetin beta (Epo-b)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control group (irinotecan or cisplatin without Epo-b)
Number of subjects: 118
Study: 22318061

Group type: EXPERIMENTAL
Intervention: Ligasure hemorrhoidectomy (LH)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Stapled hemorrhoidectomy (SH)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 98
Study: 20875231

Group type: EXPERIMENTAL
Intervention: 300 mg Tenofovir (TFV) + 200 mg Emtricitabine (FTC) + 300 mg Lamivudine (3TC) tablet formulation
Number of subjects: 43
Study: 18603377

Group type: EXPERIMENTAL
Intervention: Patient Controlled Sedation (PCS) with propofol/alfentanil
Number of subjects: 11

Group type: COMPARATOR
Intervention: Anaesthetist Controlled Sedation (ACS)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Patient Controlled Sedation (PCS)
Number of subjects: 11
Study: 15818478

Group type: EXPERIMENTAL
Intervention: Phase-inversion harmonic imaging (PIHI)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Conventional B-mode ultrasound (US)
Number of subjects: 41
Study: 11594641

Group type: EXPERIMENTAL
Intervention: Walking training on a treadmill with body weight support (BWS) for 30 minutes, 5 days a week
Number of subjects: 73

Group type: COMPARATOR
Intervention: Walking training on the ground according to the Motor Relearning Programme (MRP) for 30 minutes, 5 days a week
Number of subjects: 73
Study: 9641613

Group type: EXPERIMENTAL
Intervention: HIV+ subjects
Number of subjects: 14

Group type: COMPARATOR
Intervention: HIV- subjects
Number of subjects: 14
Study: 8039850

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 131
Study: 2647025

Group type: EXPERIMENTAL
Intervention: Tourniquet
Number of subjects: 26

Group type: COMPARATOR
Intervention: No tourniquet
Number of subjects: 26